ARGs are associated with the development and prognosis of various cancers, including ovarian cancer (Qian et al., 2023), thyroid cancer (Tang et al., 2024), and renal cell carcinoma (He et al., 2023). This evidence concerns the gene SERPINA2 and ovarian carcinoma.